ABSTRACT
Posttraumatic pseudoaneurysms of the hepatic artery are rare and usually occur as a complication of open abdominal trauma. Even less common is the coexisting presence of enteric fistulization. We report a patient with upper gastrointestinal hemorrhage occurring 3 years after blunt abdominal trauma resulting from a pseudoaneurysm of the proper hepatic artery with duodenal fistulization. The patient was treated successfully by ligation of the proper hepatic artery and closure of the duodenal opening.
Subject(s)
Abdominal Injuries/complications , Aneurysm, False/etiology , Duodenal Diseases/etiology , Hepatic Artery/injuries , Intestinal Fistula/etiology , Wounds, Nonpenetrating/complications , Adult , Aneurysm, False/diagnostic imaging , Duodenal Diseases/diagnostic imaging , Gastrointestinal Hemorrhage/etiology , Humans , Intestinal Fistula/diagnostic imaging , Male , Radiography , Time FactorsABSTRACT
Acute tubular necrosis (ATN) represents a serious problem in kidney transplantation. We have reviewed the causes and effects of ATN on kidney transplant patients treated in our hospital between June 1981 and December 1992. We analyzed 359 consecutive kidney transplants performed in 338 patients (213 male and 125 female). There were 311 first grafts. The actuarial functional graft survival (AFGS) was 85% at 1 year and 58.2% at 10 years. The incidence of long-term chronic rejection, the 1-year creatinine blood level (CBL) and the AFGS are summarized: [table: see text] The donor age and the PRA level were significantly correlated with ATN occurrence. ATN after transplantation was associated with a poorer function and survival of the kidney graft. Better donor and patient selection could decrease the occurrence of ATN, thus improving the graft outcome.
Subject(s)
Graft Rejection/epidemiology , Graft Survival , Kidney Transplantation/mortality , Kidney Tubular Necrosis, Acute/mortality , Canada/epidemiology , Chronic Disease , Diabetes Mellitus/surgery , Female , Glomerulonephritis/surgery , Graft Rejection/etiology , Humans , Incidence , Kidney Transplantation/adverse effects , Kidney Tubular Necrosis, Acute/etiology , Male , Nephritis, Interstitial/surgery , Postoperative Complications , Treatment FailureABSTRACT
Two cases of liver angiomyolipoma (AML) are presented. The first case has the classical imaging findings previously reported. The second case has no fat content on the various imaging modalities. AML should probably be included in the differential diagnosis of any hypervascular lesion of the liver. Preoperative diagnosis with core biopsy is possible.
Subject(s)
Angiomyolipoma/diagnosis , Liver Neoplasms/diagnosis , Adult , Aged , Angiomyolipoma/diagnostic imaging , Angiomyolipoma/pathology , Female , Humans , Liver Neoplasms/diagnostic imaging , Liver Neoplasms/pathology , Tomography, X-Ray Computed , UltrasonographySubject(s)
Cyclosporine/therapeutic use , Graft Survival , Kidney Transplantation/immunology , Administration, Oral , Adult , Cyclosporine/administration & dosage , Cyclosporine/blood , Drug Administration Schedule , Female , Humans , Infusions, Intravenous , Male , Methylprednisolone/therapeutic use , Middle Aged , Tissue Donors , Transplantation, HomologousSubject(s)
Antioxidants/pharmacology , Graft Survival , Intestine, Small/pathology , Ischemia , Lipid Peroxidation/drug effects , Organ Preservation Solutions , Pregnatrienes/pharmacology , Reperfusion Injury/prevention & control , Tissue Preservation/methods , Adenosine , Allopurinol , Animals , Cold Temperature , Edetic Acid , Glutathione , Hypertonic Solutions , Insulin , Male , Raffinose , Rats , Rats, Inbred WF , TemperatureSubject(s)
Graft Rejection , Graft vs Host Disease/prevention & control , Immunosuppressive Agents/therapeutic use , Intestine, Small/transplantation , Polyenes/therapeutic use , Transplantation, Homologous/immunology , Animals , Graft Survival , Graft vs Host Disease/immunology , Rats , Rats, Inbred BN , Rats, Inbred Lew , Rats, Inbred Strains , Sirolimus , Species SpecificityABSTRACT
Allograft rejection remains the single largest impediment to success in the field of transplantation. While OKT3 therapy has proven to be a significant advancement, many grafts are still lost. Late treatment, subtherapeutic OKT3 levels, anti-OKT3 antibodies, and OKT3-induced class II antigen expression are possible explanations. To determine the mechanism of OKT3 resistant rejection we propagated and characterized infiltrating T cells from the biopsy of a liver transplant patient who was rejecting while on prophylactic OKT3. The T lymphocytes demonstrated allospecific proliferation and interleukin 2 (IL2) production and showed a high degree of cytolysis of donor splenocytes. CD3 epsilon monoclonal antibodies (Mab) in concentrations up to 100 micrograms/ml did not inhibit lysis. In contrast, T lymphocytes derived from rejecting allografts of patients receiving cyclosporine and prednisone were readily inhibited from killing by CD3 epsilon Mab at doses of 1 microgram/ml. Furthermore, allospecific proliferation and IL2 production were not inhibited in the OKT3-treated patient by the addition of CD3 epsilon MaB. Incomplete modulation of the CD3-TCR complex was noted after a 72-hr incubation with CD3 epsilon Mab. The T cells did demonstrate other intact CD3-mediated functions such as a rise in intracellular calcium and CD3-dependent cytotoxicity. These results should alert clinicians that CD3 resistant cytotoxic T cells can emerge during OKT3 therapy and may cause rejection. Immunotherapy that targets additional cell surface structures may be of benefit.
Subject(s)
Antibodies, Monoclonal/therapeutic use , Antigens, CD/immunology , Antigens, Differentiation, T-Lymphocyte/immunology , Graft Rejection , Liver Transplantation , Receptors, Antigen, T-Cell/immunology , T-Lymphocytes, Cytotoxic/immunology , CD3 Complex , Cytotoxicity, Immunologic , Humans , Male , Middle Aged , Transplantation, HomologousABSTRACT
Portasystemic (PS) shunts have been regarded as a relative contraindication to hepatic transplantation (HT) because of the potential for increased technical difficulties during the transplant operation. We compared operative blood loss, morbidity and mortality in 27 patients with PS shunts and 147 patients with no shunts (NS) who underwent HT. The PS shunt group included 12 portocaval (PC), eight mesocaval, four central splenorenal and four distal splenorenal shunts. The PS shunt and NS groups were similar with respect to age, preoperative medical status and ABO blood group matching between donors and recipients. There were no significant differences in the mean (plus or minus S.D.) intraoperative blood transfusion (9.1 +/- 7.6 versus 9.2 +/- 11.0 units), mean (plus or minus S.D.) duration of anesthesia (8.1 +/- 1.4 versus 7.8 +/- 1.5 hours) and operative mortality (7 versus 11 per cent) between the PS shunt and NS groups, respectively. Complications of the biliary tract were significantly higher in the PS shunt group (22.0 versus 5.4 per cent, p less than 0.01) but they did not increase the mortality rate. We conclude that a prior PS shunt should not influence the decision to accept patients for HT. PS shunts remain a reasonable surgical option for patients with cirrhosis and variceal hemorrhage (refractory to sclerotherapy) who, by virtue of good hepatic function, do not merit immediate HT.
Subject(s)
Liver Transplantation , Portasystemic Shunt, Surgical , Actuarial Analysis , Adult , Anastomosis, Roux-en-Y/adverse effects , Contraindications , Esophageal and Gastric Varices/surgery , Evaluation Studies as Topic , Female , Gastrointestinal Hemorrhage/surgery , Humans , Liver Cirrhosis/surgery , Liver Transplantation/methods , Liver Transplantation/mortality , Male , Middle Aged , Portasystemic Shunt, Surgical/methods , Reoperation , Retrospective Studies , Sex Factors , Time FactorsSubject(s)
Antibodies, Monoclonal/therapeutic use , Liver Transplantation/immunology , Adult , Antigens, Differentiation, T-Lymphocyte/immunology , CD3 Complex , Child , Graft Rejection , Humans , Immunosuppression Therapy/methods , Muromonab-CD3 , Receptors, Antigen, T-Cell/immunology , T-Lymphocyte Subsets/immunologyABSTRACT
Simultaneous harvesting of the liver and whole pancreas is usually not performed because it is believed that the shared vascular supply of both organs is incompatible with safe grafting. A careful review of the vascular anatomy, however, shows that simultaneous removal of the two organs is feasible, and a technique is described by which the liver is revascularized in the recipient through the celiac axis or the common hepatic artery and the pancreas is revascularized through the superior mesenteric and splenic arteries. When the vascular supply is abnormal, reconstruction of the vascular tree of one or both organs may be needed. The results of this technique used on 10 recipients are analysed.